JF7 Jointformula
JF7 Research Study
While other products often derive their claims from studies they did not actually conduct, we are so confident in our formula, we commissioned a clinical scientific research study at a specialized testing facility in Irvine, California.

The 60-day study began with 32 non-compensated participants and was supervised by a Professor of Kinesiology from University of Southern California. By the end of the study, a total of 25 people remained and completed the study in its entirety. In addition to the tests conducted during the study as described in the study protocol, interviews were conducted with participants on day 1, day 7, day 30 and day 60.

These interviews were documented and the results can be viewed in the Testimonials page; or by clicking here.

To view and/or download the full study protocol and study result summary, please click here
Dr. Robert Girandola conducting various tests for non-compensated participants suffering from joint discomfort during JF7’s Research Study in a specialized testing facility in Irvine, CA

STUDY RESULT SUMMARY

Figure 1 (click here to zoom)

It was noted that of the 25 subjects that completed the 1st 7 days 100% claimed a level of satisfaction with the nutritional supplement called JF-7. (See figure 1)

The dosage of 3 tablets a day was most effective. When subjects were asked to change dosage to 2 tablets a day 50% claimed their discomfort was back. Once back at 3 tablets discomfort diminished.

The study subjects experienced a measured reduction in joint discomfort with the most significant reduction of discomfort noted in the knees and lower back.

The results of the study are consistent with other prior research regarding Glucosamine supplementation in that it was fully anticipated that the JF-7 daily dosages would produce noticeable reductions in joint discomfort.

Of the 18 subjects that completed the full 60 day study the average discomfort level over all was, including knees, back, hands, wrists, ankles, and shoulders, 6.4 out of 10. At the end of the 60 day term the average level was .67, a 90% decrease in the discomfort over a 60 day Period... (See Result 1 Figure 2)

Of those 18 participants that completed the full 60 day term, 15 complained of discomfort in either back, knee or a combination of the two. The average level of pain for these combined areas was 6.8 before and .58 after the 60 day trial – a 91% reduction. (See Result 2 Figure 3)
Figure 2 (click here to zoom)
Figure 3 (click here to zoom)



Copyrights © LifePharm 2012. All Rights reserved. - Privacy Policy